MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Revenue
$4,283,979
Net Income
-$1,156,208
Net Profit Margin
-26.99%
EPS
-$0.45
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-09-30
Net product sales
4,283,979
3,752,142
3,080,158
2,654,186
Cost of goods sold
101,977
167,679
41,613
104,024
Research and development
5,320
8,413
42,783
11,677
Selling, general and administrative
5,314,370
5,134,902
4,297,505
3,824,142
Total operating expenses
5,421,667
5,310,994
4,381,901
3,939,843
Loss from operations
-1,137,688
-1,558,852
-1,301,743
-1,285,657
Interest income
107,507
112,534
118,853
99,294
Interest expense
126,027
124,658
123,288
126,027
Total other expense
-18,520
-12,124
-4,435
-26,733
Net loss
-1,156,208
-1,570,976
-1,306,178
-1,312,390
Basic EPS
-0.45
-0.62
-0.51
-0.94
Diluted EPS
-0.45
-0.62
-0.51
-0.94
Basic Average Shares
2,557,408
2,553,174
2,548,684
1,399,882
Diluted Average Shares
2,557,408
2,553,174
2,548,684
1,399,882
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
EVOK Income Statement Sankey Diagram
Sankey diagram visualizing EVOK income statement for the period
Net loss
-$1,156,208
(11.90%↑ Y/Y)
Loss from operations
-$1,137,688
(11.51%↑ Y/Y)
Total other expense
-$18,520
(30.72%↑ Y/Y)
Net product sales
$4,283,979
(61.40%↑ Y/Y)
Interest income
$107,507
(8.27%↑ Y/Y)
Total operating
expenses
$5,421,667
(37.61%↑ Y/Y)
Interest expense
$126,027
(0.00%↑ Y/Y)
Selling, general and
administrative
$5,314,370
(38.97%↑ Y/Y)
Cost of goods sold
$101,977
(-1.97%↓ Y/Y)
Research and development
$5,320
(-54.44%↓ Y/Y)
Buy us a coffee
Evoke Pharma Inc (EVOK)
Evoke Pharma Inc (EVOK)